*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Study of Mifepristone Vs Misoprostol as Pre-induction Cervical Ripening Agent in Term Pregnancy

Author: NIDHI SINGH, NEEMA ACHARYA, PRIYANKA SINGH, KIRTI SINGH, CHETAN SUDHAKARRAO GODE
Abstract: Background: The evidence in the literature is still inconclusive about the effectiveness and safety of the various cervical ripening agents. Out of a spectrum of the cervical ripening agents available today obstetricians need to choose a ripening agent which has higher probability of providing a successful outcome which in this case is successful vaginal delivery. Objectives: To study the effectiveness and safety of oral mifepristone as a pre-induction cervical ripening agent in term pregnancy. To study the effectiveness and safety of oral misoprostol as a pre-induction cervical ripening agent in term pregnancy. Methodology: A prospective observational study including 250 women at term between 37 to 40 weeks of gestation was conducted in ABVRH Sawangi. women who received misoprostol were categorised in group A and women who received mifepristone were categorised as group B. The changes in bishop score after administration of the above two drugs were observed and compared. Results: the study will include 250 antenatal women who will be admitted for induction of labour at term. Women who have been administered mifepristone will have a better bishop score as compared to misoprostol and in turn will have a higher rate of vaginal delivery with minimal rates of perinatal and maternal morbidity and mortality. Women on misoprostol will have a higher rate of caesarean sections and requirement of obstetric interventions and nicu admissions for neonates. Conclusion: There will be significant difference in improvement in cervical ripening score as well their effect on labour outcome when mifepristone and misoprostol are used as pre-induction cervical ripening agent in term pregnancy.
Keyword: Misoprostol, mifepristone, pre-induction cervical ripening agent.
DOI: https://doi.org/10.31838/ijpr/2019.11.04.506
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free